Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A03743 | 33880813 | Phytother Res | Effect of Portulaca Oleracea (purslane) extract on liver enzymes, lipid profile, and glycemic status in nonalcoholic fatty liver disease: A randomized, double-blind clinical trial. | 2021 | Details |
| A03744 | 33879971 | J Clin Biochem Nutr | Vitamin B6 efficacy in the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, single-center trial. | 2021 | Details |
| A03745 | 33879970 | J Clin Biochem Nutr | Comparison of dapagliflozin and teneligliptin in nonalcoholic fatty liver disease patients without type 2 diabetes mellitus: a prospective randomized study. | 2020 | Details |
| A03746 | 33879861 | Exp Mol Med | The interplay of microRNAs and transcription factors in autophagy regulation in nonalcoholic fatty liver disease. | 2021 | Details |
| A03747 | 33879188 | Lipids Health Dis | TWIST2 and the PPAR signaling pathway are important in the progression of nonalcoholic steatohepatitis. | 2021 | Details |
| A03748 | 33879084 | BMC Gastroenterol | Evaluating the prevalence and severity of NAFLD in primary care: the EPSONIP study protocol. | 2021 | Details |
| A03749 | 33878988 | Expert Rev Gastroenterol Hepatol | Liver-spleen axis in nonalcoholic fatty liver disease. | 2021 | Details |
| A03750 | 33878875 | Arch Iran Med | Hepatic Steatosis and Fibrosis in Type 2 Diabetes: A Risk-Based Approach to Targeted Screening. | 2021 | Details |
| A03751 | 33878156 | J Clin Endocrinol Metab | NAFLD and Liver Fibrosis Are Not Associated With Reduced Femoral Bone Mineral Density in the General US Population. | 2021 | Details |
| A03752 | 33878116 | PLoS One | Leaf powder supplementation of Senna alexandrina ameliorates oxidative stress, inflammation, and hepatic steatosis in high-fat diet-fed obese rats. | 2021 | Details |
| A03753 | 33877366 | Diabetologia | Liver-targeting drugs and their effect on blood glucose and hepatic lipids. | 2021 | Details |
| A03754 | 33877249 | Food Funct | Pterostilbene modifies triglyceride metabolism in hepatic steatosis induced by high-fat high-fructose feeding: a comparison with its analog resveratrol. | 2021 | Details |
| A03755 | 33876811 | Food Funct | The role of iron homeostasis in adipocyte metabolism. | 2021 | Details |
| A03756 | 33875327 | Trends Endocrinol Metab | RIPK1 targeting protects against obesity and atherosclerosis. | 2021 | Details |
| A03757 | 33873073 | J Pharm Biomed Anal | Investigation of the therapeutic effect of Yinchen Wuling Powder on CCl4-induced hepatic fibrosis in rats by 1H NMR and MS-based metabolomics analysis. | 2021 | Details |
| A03758 | 33872860 | Mol Metab | Iron aggravates hepatic insulin resistance in the absence of inflammation in a novel db/db mouse model with iron overload. | 2021 | Details |
| A03759 | 33872646 | Environ Res | Serum selenium and non-alcoholic fatty liver disease (NAFLD) in U.S. adults: National Health and Nutrition Examination Survey (NHANES) 2011-2016. | 2021 | Details |
| A03760 | 33872605 | J Lipid Res | Carboxylesterase 2 proteins are efficient diglyceride and monoglyceride lipases possibly implicated in metabolic disease. | 2021 | Details |
| A03761 | 33872099 | Scand J Gastroenterol | Etiologies and outcomes of cirrhosis in a large contemporary cohort. | 2021 | Details |
| A03762 | 33871465 | J Vis Exp | Analysis of Liver Microenvironment during Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish. | 2021 | Details |
| A03763 | 33871418 | Curr Opin Clin Nutr Metab Care | Beyond weight loss in nonalcoholic fatty liver disease: the role of carbohydrate restriction. | 2021 | Details |
| A03764 | 33871391 | J Chin Med Assoc | Differentiation of clinical patterns and survival outcomes of hepatocellular carcinoma on hepatitis B and nonalcoholic fatty liver disease. | 2021 | Details |
| A03765 | 33871240 | J Sports Med Phys Fitness | The effect of combined exercises on the plasma levels of retinol-binding protein 4 and its relationship with insulin resistance and hepatic fat content in postmenopausal women with nonalcoholic fatty liver disease. | 2021 | Details |
| A03766 | 33871224 | Minerva Gastroenterol (Torino) | Gut microbiota and non-alcoholic fatty liver disease. | 2021 | Details |
| A03767 | 33871081 | J Gastroenterol Hepatol | Interplay between non-alcoholic fatty liver disease and cardiovascular risk in an asymptomatic general population. | 2021 | Details |
| A03768 | 33870623 | Mol Nutr Food Res | Nicotinamide Protects Against Diet-Induced Body Weight Gain, Increases Energy Expenditure, and Induces White Adipose Tissue Beiging. | 2021 | Details |
| A03769 | 33869707 | Pract Lab Med | High-throughput nuclear magnetic resonance measurement of citrate in serum and plasma in the clinical laboratory. | 2021 | Details |
| A03770 | 33869312 | Front Cardiovasc Med | The Roles and Pharmacological Effects of FGF21 in Preventing Aging-Associated Metabolic Diseases. | 2021 | Details |
| A03771 | 33869077 | Front Cell Infect Microbiol | The Role of Gut Microbiota in Duodenal-Jejunal Bypass Surgery-Induced Improvement of Hepatic Steatosis in HFD-Fed Rats. | 2021 | Details |
| A03773 | 33868609 | Gastroenterol Hepatol Bed Bench | Efficacy of vitamin D supplementation on adult patients with non-alcoholic fatty liver disease: a single-center experience. | 2021 | Details |
| A03774 | 33868403 | J Oncol | The Gene Signature Associated with Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A03775 | 33868162 | Front Endocrinol (Lausanne) | Association Between 10-Year Fracture Probability and Nonalcoholic Fatty Liver Disease With or Without Sarcopenia in Korean Men: A Nationwide Population-Based Cross-Sectional Study. | 2021 | Details |
| A03776 | 33867442 | Eur J Gastroenterol Hepatol | Small intestinal bacterial overgrowth and orocecal transit time in patients of nonalcoholic fatty liver disease. | 2021 | Details |
| A03777 | 33867441 | Eur J Gastroenterol Hepatol | Weight change and resolution of fatty liver in normal weight individuals with nonalcoholic fatty liver disease. | 2021 | Details |
| A03778 | 33867326 | Pak J Pharm Sci | Effects of shikonin from Zicao on high-fat diet-induced nonalcoholic fatty liver disease in rats. | 2020 | Details |
| A03779 | 33867228 | Eur J Intern Med | Adiponectin involved in portal flow hepatic extraction of 13C-methacetin in obesity and non-alcoholic fatty liver. | 2021 | Details |
| A03780 | 33866274 | J Stroke Cerebrovasc Dis | Liver Fibrosis is Associated with Ischemic Stroke Risk in Women but not Men: The REGARDS Study. | 2021 | Details |
| A03781 | 33865909 | J Hepatol | Muscle fat content is strongly associated with NASH: A longitudinal study in patients with morbid obesity. | 2021 | Details |
| A03782 | 33865898 | Metabolism | Collagen β(1-O) galactosyltransferase 2 deficiency contributes to lipodystrophy and aggravates NAFLD related to HMW adiponectin in mice. | 2021 | Details |
| A03783 | 33865049 | J Pharm Biomed Anal | Serum untargeted metabolomics delineates the metabolic status in different subtypes of non-alcoholic fatty liver disease. | 2021 | Details |
| A03784 | 33865013 | Biomed Pharmacother | Salvia-Nelumbinis naturalis extract protects mice against MCD diet-induced steatohepatitis via activation of colonic FXR-FGF15 pathway. | 2021 | Details |
| A03785 | 33864798 | Metabolism | Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk. | 2021 | Details |
| A03786 | 33864571 | Mol Cell Biochem | Upregulated SOCC and IP3R calcium channels and subsequent elevated cytoplasmic calcium signaling promote nonalcoholic fatty liver disease by inhibiting autophagy. | 2021 | Details |
| A03788 | 33862553 | Int Immunopharmacol | Alpinetin exerts anti-inflammatory, anti-oxidative and anti-angiogenic effects through activating the Nrf2 pathway and inhibiting NLRP3 pathway in carbon tetrachloride-induced liver fibrosis. | 2021 | Details |
| A03789 | 33862461 | Biochem Biophys Res Commun | Canagliflozin ameliorates hepatic fat deposition in obese diabetic mice: Role of prostaglandin E2. | 2021 | Details |
| A03790 | 33862417 | Diabetes Metab Syndr | Non-alcoholic fatty liver disease and clinical outcomes in patients with COVID-19: A comprehensive systematic review and meta-analysis. | 2021 | Details |
| A03791 | 33862225 | Clin Gastroenterol Hepatol | Maternal and Perinatal Risk Factors for Pediatric Nonalcoholic Fatty Liver Disease: A Systematic Review. | 2021 | Details |
| A03792 | 33862147 | Biochim Biophys Acta Mol Basis Dis | Emerging functions of the nuclear receptor LRH-1 in liver physiology and pathology. | 2021 | Details |
| A03793 | 33862107 | Life Sci | Naringin improves lipid metabolism in a tissue-engineered liver model of NAFLD and the underlying mechanisms. | 2021 | Details |
| A03794 | 33862045 | Metabolism | Determinants of hepatic insulin clearance - Results from a Mendelian Randomization study. | 2021 | Details |
| A03796 | 33861449 | Adv Exp Med Biol | Beneficial Effects of Plant-Derived Natural Products on Non-alcoholic Fatty Liver Disease. | 2021 | Details |
| A03797 | 33861444 | Adv Exp Med Biol | Medicinal Plants and Phytochemicals Regulating Insulin Resistance and Glucose Homeostasis in Type 2 Diabetic Patients: A Clinical Review. | 2021 | Details |
| A03798 | 33861434 | Adv Exp Med Biol | The Effect of Curcumin Phytosome on the Treatment of Patients with Non-alcoholic Fatty Liver Disease: A Double-Blind, Randomized, Placebo-Controlled Trial. | 2021 | Details |
| A03800 | 33860630 | FEBS J | Liver macrophages and inflammation in physiology and physiopathology of non-alcoholic fatty liver disease. | 2021 | Details |
| A03801 | 33860590 | Phytother Res | Administration of isoliquiritigenin prevents nonalcoholic fatty liver disease through a novel IQGAP2-CREB-SIRT1 axis. | 2021 | Details |
| A03802 | 33860214 | ACS Pharmacol Transl Sci | Differential Therapeutic Effects of FXR Activation, sEH Inhibition, and Dual FXR/sEH Modulation in NASH in Diet-Induced Obese Mice. | 2021 | Details |
| A03803 | 33860199 | ACS Pharmacol Transl Sci | Peripherally Selective CB1 Receptor Antagonist Improves Symptoms of Metabolic Syndrome in Mice. | 2021 | Details |
| A03804 | 33860188 | ACS Pharmacol Transl Sci | Pyruvate Dehydrogenase as a Therapeutic Target for Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A03805 | 33860119 | Hepatol Commun | Serum Bile Acid, Vitamin E, and Serotonin Metabolites Are Associated With Future Liver-Related Events in Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A03806 | 33860118 | Hepatol Commun | Sex and Menopause Modify the Effect of Single Nucleotide Polymorphism Genotypes on Fibrosis in NAFLD. | 2021 | Details |
| A03807 | 33860117 | Hepatol Commun | Lipoprotein Insulin Resistance Index Reflects Liver Fat Content in Patients With Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A03808 | 33860116 | Hepatol Commun | Effects of Resmetirom on Noninvasive Endpoints in a 36-Week Phase 2 Active Treatment Extension Study in Patients With NASH. | 2021 | Details |
| A03809 | 33860115 | Hepatol Commun | Type IV Collagen 7S Is the Most Accurate Test For Identifying Advanced Fibrosis in NAFLD With Type 2 Diabetes. | 2020 | Details |
| A03810 | 33860113 | Hepatol Commun | Editorial: Noninvasive Fibrosis Biomarkers in Patients With NASH With Diabetes. | 2021 | Details |
| A03811 | 33860093 | JGH Open | Non-alcoholic fatty liver disease in premenopausal women with polycystic ovary syndrome: A systematic review and meta-analysis. | 2021 | Details |
| A03812 | 33860040 | Biomed Res Int | The Relationship between Hepatic Myeloid-Derived Suppressor Cells and Clinicopathological Parameters in Patients with Chronic Liver Disease. | 2021 | Details |
| A03813 | 33859820 | Biomed Rep | Effects of obesity and 10 weeks metformin treatment on liver steatosis. | 2021 | Details |
| A03814 | 33859484 | Diabetes Metab Syndr Obes | Significant Association Between Left Ventricular Diastolic Dysfunction, Left Atrial Performance and Liver Stiffness in Patients with Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A03815 | 33859314 | Sci Rep | Extra virgin olive oil improved body weight and insulin sensitivity in high fat diet-induced obese LDLr-/-.Leiden mice without attenuation of steatohepatitis. | 2021 | Details |
| A03816 | 33858428 | J Transl Med | Metabolic analysis of early nonalcoholic fatty liver disease in humans using liquid chromatography-mass spectrometry. | 2021 | Details |
| A03817 | 33857709 | Environ Int | Effects of environmental contaminants in water resources on nonalcoholic fatty liver disease. | 2021 | Details |
| A03818 | 33857628 | Free Radic Biol Med | Hepatocyte-specific deletion of Nlrp6 in mice exacerbates the development of non-alcoholic steatohepatitis. | 2021 | Details |
| A03819 | 33857552 | Adv Drug Deliv Rev | Cellular protein markers, therapeutics, and drug delivery strategies in the treatment of diabetes-associated liver fibrosis. | 2021 | Details |
| A03820 | 33857511 | Int J Biol Macromol | Walnut green husk polysaccharides prevent obesity, chronic inflammatory responses, nonalcoholic fatty liver disease and colonic tissue damage in high-fat diet fed rats. | 2021 | Details |
| A03821 | 33857017 | Cancer Epidemiol Biomarkers Prev | Modest Impact of Liver Transplantation on Hepatocellular Carcinoma Mortality in the United States, Findings from The Transplant Cancer Match (TCM) Study. | 2021 | Details |
| A03822 | 33856608 | Clin Exp Nephrol | Non-invasive fibrosis assessments of non-alcoholic fatty liver disease associated with low estimated glomerular filtration rate among CKD patients: the Fukuoka Kidney disease Registry Study. | 2021 | Details |
| A03823 | 33856246 | Expert Opin Emerg Drugs | Emerging synthetic drugs for the treatment of liver cirrhosis. | 2021 | Details |
| A03826 | 33856122 | ChemMedChem | Development and in vitro Profiling of Dual FXR/LTA4H Modulators. | 2021 | Details |
| A03827 | 33856023 | Hum Mol Genet | Allele-specific variation at APOE increases nonalcoholic fatty liver disease and obesity but decreases risk of Alzheimer's disease and myocardial infarction. | 2021 | Details |
| A03828 | 33855952 | Acta Medica (Hradec Kralove) | The Connection between MicroRNAs from Visceral Adipose Tissue and Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A03829 | 33855386 | Minerva Endocrinol (Torino) | Relationship between plasma 12,13-diHOME level and nonalcoholic fatty liver disease in patients with type 2 diabetes and obesity. | 2021 | Details |
| A03830 | 33855376 | Minerva Surg | NAFLD: a multi-faceted morbid spectrum with uncertain diagnosis and complicated management. | 2021 | Details |
| A03831 | 33854987 | J Hepatocell Carcinoma | NAFLD-Associated HCC: Progress and Opportunities. | 2021 | Details |
| A03832 | 33854559 | Evid Based Complement Alternat Med | The Efficacy of Plantago major Seed on Liver Enzymes in Nonalcoholic Fatty Liver Disease: A Randomized Double-Blind Clinical Trial. | 2021 | Details |
| A03833 | 33854482 | Front Endocrinol (Lausanne) | SHBG as a Marker of NAFLD and Metabolic Impairments in Women Referred for Oligomenorrhea and/or Hirsutism and in Women With Sexual Dysfunction. | 2021 | Details |
| A03834 | 33853848 | BMJ Open Diabetes Res Care | Interleukin-6 mediated exercise-induced alleviation of adiposity and hepatic steatosis in mice. | 2021 | Details |
| A03835 | 33853719 | Nutr Metab Cardiovasc Dis | The HSD17B13 rs72613567 variant is associated with lower levels of albuminuria in patients with biopsy-proven nonalcoholic fatty liver disease. | 2021 | Details |
| A03836 | 33853536 | BMC Gastroenterol | Identifying potential biomarkers of nonalcoholic fatty liver disease via genome-wide analysis of copy number variation. | 2021 | Details |
| A03837 | 33852720 | Clin Infect Dis | Growth Hormone Releasing Hormone Reduces Circulating Markers of Immune Activation in Parallel with Effects on Hepatic Immune Pathways in Individuals with HIV-infection and Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A03838 | 33852613 | PLoS One | Intrahepatic distribution of nerve fibers and alterations due to fibrosis in diseased liver. | 2021 | Details |
| A03839 | 33852514 | Eur J Gastroenterol Hepatol | Incidences of hypothyroidism and autoimmune thyroiditis are increased in patients with nonalcoholic fatty liver disease. | 2021 | Details |
| A03840 | 33852508 | Eur J Gastroenterol Hepatol | The role of nursing care in the type 2 diabetes treatment associated with chronic liver diseases. | 2022 | Details |
| A03841 | 33851883 | Expert Rev Gastroenterol Hepatol | NAFLD and renal function in children: is there a genetic link? | 2021 | Details |
| A03842 | 33851592 | Wiad Lek | THE ROLE OF ZONULIN IN THE DEVELOPMENT OF LIVER FIBROSIS IN OBESE ADOLESCENTS. | 2021 | Details |
| A03843 | 33851458 | Hepatology | Hepatic Fibroblast Growth Factor 21 Is Involved in Mediating Functions of Liraglutide in Mice With Dietary Challenge. | 2021 | Details |
| A03844 | 33849437 | BMC Gastroenterol | Relationship between body composition and the histology of non-alcoholic fatty liver disease: a cross-sectional study. | 2021 | Details |
| A03845 | 33849361 | Expert Opin Drug Discov | The identification of farnesoid X receptor modulators as treatment options for nonalcoholic fatty liver disease. | 2021 | Details |
| A03846 | 33849107 | Ann Palliat Med | Qinghua Fang inhibits high-fat diet-induced non-alcoholic fatty liver disease by modulating gut microbiota. | 2021 | Details |
| A03847 | 33849075 | Nucleic Acids Res | iNetModels 2.0: an interactive visualization and database of multi-omics data. | 2021 | Details |
| A03848 | 33848667 | Clin Res Hepatol Gastroenterol | Low serum alkaline phosphatase levels in patients with chronic liver diseases: Possible contributions to disease pathogenesis. | 2021 | Details |